LIF and breast cancer: It has been reported that LIF oncogenic activity is mediated by STAT3 phosphorylation and translocation to the nuclei, and our group has reported that activation of this transcription factor in mammary tumor cells is dependent on paracrine/autocrine LIF secretion [69].